Literature DB >> 14632768

Anti-idiotype vaccines.

Helen McCarthy1, Christian H Ottensmeier, Terry J Hamblin, Freda K Stevenson.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 14632768     DOI： 10.1046/j.1365-2141.2003.04698.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  4 in total

1.  Humoral immune response and immunoglobulin G Fc receptor genotype are associated with better clinical outcome following idiotype vaccination in follicular lymphoma patients regardless of their response to induction chemotherapy.

Authors:  Wen-Kai Weng; Debra Czerwinski; Ronald Levy
Journal:  Blood       Date:  2006-10-10       Impact factor: 22.113

2.  Idiotype vaccines for lymphoma: Potential factors predicting the induction of immune responses.

Authors:  Susana Inoges; Ascension Lopez-Diaz de Cerio; Helena Villanueva; Fernando Pastor; Elena Soria; Maurizio Bendandi
Journal:  World J Clin Oncol       Date:  2011-06-10

3.  Plant virus particles carrying tumour antigen activate TLR7 and Induce high levels of protective antibody.

Authors:  Jantipa Jobsri; Alex Allen; Deepa Rajagopal; Michael Shipton; Kostya Kanyuka; George P Lomonossoff; Christian Ottensmeier; Sandra S Diebold; Freda K Stevenson; Natalia Savelyeva
Journal:  PLoS One       Date:  2015-02-18       Impact factor: 3.240

Review 4.  Immunomodulatory potential of anti-idiotypic antibodies for the treatment of autoimmune diseases.

Authors:  Shing Yi Pan; Yvonne Cashinn Chia; Hui Rong Yee; Angelina Ying Fang Cheng; Clarice Evey Anjum; Yenny Kenisi; Mike Ks Chan; Michelle Bf Wong
Journal:  Future Sci OA       Date:  2020-10-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.